Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Self-injurious Behavior in Children With Autism Spectrum Disorder
NCT03008889Phase 2Completed
- Sponsor
- Emory University
- Start
- Jul 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in Autism Spectrum Disorder (ASD), sponsored by Emory University. Started Jul 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03008889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008889.